These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18926335)

  • 1. Enteric coating is a possible cause of aspirin resistance.
    Kapoor JR
    J Am Coll Cardiol; 2008 Oct; 52(15):1276-7; author reply 1277. PubMed ID: 18926335
    [No Abstract]   [Full Text] [Related]  

  • 2. Enteric-coated aspirin and cyclooxygenase inhibition.
    Svensson J; Mettinger KL; Blombäck M
    Thromb Res; 1983 Jan; 29(1):99-102. PubMed ID: 6404001
    [No Abstract]   [Full Text] [Related]  

  • 3. Enteric coating can lead to reduced antiplatelet effect of low-dose acetylsalicylic acid.
    Haastrup PF; Grønlykke T; Jarbøl DE
    Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):212-5. PubMed ID: 25469781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In brief: enteric-coated aspirin as an antiplatelet drug.
    Med Lett Drugs Ther; 2014 Apr; 56(1441):36. PubMed ID: 24759295
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of enteric-coated, low-dose aspirin on parameters of platelet function.
    Van Hecken A; Juliano ML; Depré M; De Lepeleire I; Arnout J; Dynder A; Wildonger L; Petty KJ; Gottesdiener K; De Hoon JN
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1683-8. PubMed ID: 12197849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteric-coated aspirin, platelet cyclooxygenase activity and function.
    Rao GH; Radh E; Johnson GJ; White JG
    Prostaglandins Leukot Med; 1984 Mar; 13(3):341-7. PubMed ID: 6425869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of low dose enteric-coated aspirin on platelet function.
    Rao GH; Rao AS; White JG
    Indian Heart J; 1992; 44(6):365-70. PubMed ID: 1307083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of enteric-coated tablets of acetylsalicylic acid on platelet function].
    Nilsen DW; Thorsen LI; Haga AK; Gamst ON
    Tidsskr Nor Laegeforen; 1986 Jun; 106(16):1385-7. PubMed ID: 3750293
    [No Abstract]   [Full Text] [Related]  

  • 9. Can aspirin act only in the enterohepatic circulation to inactivate platelets?
    Brandon RA; Eadie MJ
    Med J Aust; 1987 Sep; 147(5):261. PubMed ID: 3670181
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiplatelet effect of aspirin in patients with cerebrovascular disease.
    Alberts MJ; Bergman DL; Molner E; Jovanovic BD; Ushiwata I; Teruya J
    Stroke; 2004 Jan; 35(1):175-8. PubMed ID: 14671242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of enteric-coated aspirin and inhibition of platelet thromboxane A2 and vascular prostacyclin generation in humans.
    Cerletti C; Marchi S; Lauri D; Domanin M; Lorenzi G; Urso R; Dejana E; Latini R; de Gaetano G
    Clin Pharmacol Ther; 1987 Aug; 42(2):175-80. PubMed ID: 3301151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of alternate-day regular and enteric-coated aspirin on platelet aggregation, bleeding time, and thromboxane A2 levels in bleeding-time blood.
    Stampfer MJ; Jakubowski JA; Deykin D; Schafer AI; Willett WC; Hennekens CH
    Am J Med; 1986 Sep; 81(3):400-4. PubMed ID: 3529953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the bioavailability and platelet inhibitory effects of a new enteric-coated acetylsalicylic acid preparation.
    Kelton JG; Carter CJ; Rosenfeld J; Nguyen KB
    Thromb Res; 1984 Jun; 34(6):561-6. PubMed ID: 6740573
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss.
    Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG
    Aust N Z J Med; 1977 Dec; 7(6):600-4. PubMed ID: 350214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter by Fisher and Johns regarding article, "Variable platelet response to aspirin and clopidogrel in atherothrombotic disease".
    Fisher M; Johns T
    Circulation; 2007 Nov; 116(19):e521. PubMed ID: 17984385
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin.
    Ali M; McDonald JW; Thiessen JJ; Coates PE
    Stroke; 1980; 11(1):9-13. PubMed ID: 7355437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man.
    May JA; Heptinstall S; Cole AT; Hawkey CJ
    Thromb Res; 1997 Oct; 88(2):183-92. PubMed ID: 9361371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin.
    Guthikonda S; Lev EI; Patel R; DeLao T; Bergeron AL; Dong JF; Kleiman NS
    J Thromb Haemost; 2007 Mar; 5(3):490-6. PubMed ID: 17319904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of different doses of some acetylsalicylic acid formulations on platelet function and bleeding times in healthy subjects.
    McLeod LJ; Roberts MS; Cossum PA; Vial JH
    Scand J Haematol; 1986 Apr; 36(4):379-84. PubMed ID: 3715407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease.
    Maree AO; Curtin RJ; Dooley M; Conroy RM; Crean P; Cox D; Fitzgerald DJ
    J Am Coll Cardiol; 2005 Oct; 46(7):1258-63. PubMed ID: 16198840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.